Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis

Abstract

We genotyped individuals with primary biliary cirrhosis and unaffected controls for suggestive risk loci (genome-wide association P < 1 × 10−4) identified in a previous genome-wide association study. Combined analysis of the genome-wide association and replication datasets identified IRF5-TNPO3 (combined P = 8.66 × 10−13), 17q12-21 (combined P = 3.50 × 10−13) and MMEL1 (combined P = 3.15 × 10−8) as new primary biliary cirrhosis susceptibility loci. Fine-mapping studies showed that a single variant accounts for the IRF5-TNPO3 association. As these loci are implicated in other autoimmune conditions, these findings confirm genetic overlap among such diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Association plots for the IRF5-TNPO3, 17q12-21 and MMEL1 loci.

Similar content being viewed by others

References

  1. Lindor, K.D. et al. Hepatology 50, 291–308 (2009).

    Article  Google Scholar 

  2. Hirschfield, G.M. et al. N. Engl. J. Med. 360, 2544–2555 (2009).

    Article  CAS  Google Scholar 

  3. Mitchell, M.K., Gregersen, P.K., Johnson, S., Parsons, R. & Vlahov, D. J. Urban Health 81, 301–310 (2004).

    Article  Google Scholar 

  4. Graham, R.R. et al. Proc. Natl. Acad. Sci. USA 104, 6758–6763 (2007).

    Article  CAS  Google Scholar 

  5. Sigurdsson, S. et al. Hum. Mol. Genet. 17, 872–881 (2008).

    Article  CAS  Google Scholar 

  6. Dieudé, P. et al. Arthritis Rheum. 60, 225–233 (2009).

    Article  Google Scholar 

  7. Miceli-Richard, C. et al. Arthritis Rheum. 60, 1991–1997 (2009).

    Article  CAS  Google Scholar 

  8. Bouzigon, E. et al. N. Engl. J. Med. 359, 1985–1994 (2008).

    Article  CAS  Google Scholar 

  9. Barrett, J.C. et al. Nat. Genet. 40, 955–962 (2008).

    Article  CAS  Google Scholar 

  10. Barrett, J.C. et al. Nat. Genet. 41, 703–707 (2009).

    Article  CAS  Google Scholar 

  11. Raychaudhuri, S. et al. Nat. Genet. 40, 1216–1223 (2008).

    Article  CAS  Google Scholar 

  12. Coenen, M.J. et al. Hum. Mol. Genet. 18, 4195–4203 (2009).

    Article  CAS  Google Scholar 

  13. Schotte, R., Nagasawa, M., Weijer, K., Spits, H. & Blom, B. J. Exp. Med. 200, 1503–1509 (2004).

    Article  CAS  Google Scholar 

  14. Muratori, L., Granito, A., Muratori, P., Pappas, G. & Bianchi, F.B. Clin. Liver Dis. vii. 12, 261–276 (2008).

    Article  Google Scholar 

  15. Snir, O. et al. Ann. Rheum. Dis. 68, 736–743 (2009).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This research was supported by grants from the Canadian Institutes for Health Research (MOP 74621), the Ontario Research Fund (RE01-061), the Canadian Primary Biliary Cirrhosis Society, the Canadian Foundation for Innovation, the Ben and Hilda Katz Charitable Foundation, the US National Institutes of Health (K23 DK68290, RO3 DK78527 and RO1 DK80670), the American Gastroenterological Association and the A.J. and Sigismunda Palumbo Charitable Trust. K.A.S. is a recipient of a Canada Research Chair award. We thank all the study subjects and supporting physicians as well as the technical staff of the University Health Network Analytical Genetics Technology Centre for their assistance in this research.

Author information

Authors and Affiliations

Authors

Contributions

G.M.H., X.L., C.I.A. and K.A.S. designed the study. X.L., Y.H., I.P.G., Y.L., C.X., Y.L., W.C., J.Z. and C.I.A. performed the genotyping and data analysis. G.M.H., B.D.J., C.C., A.L.M., P.M., R.P.M., J.A.O., V.A.L., D.S., C.V., C.L., P.K.G., E.J.H., K.N.L. and K.A.S. developed the clinical network and sample collection and processing framework required for case and control accrual. G.M.H., C.I.A. and K.A.S. wrote the manuscript. G.M.H., X.L., C.I.A. and K.A.S. vouch for the data and its analysis. G.M.H., C.I.A. and K.A.S. (the senior and corresponding author) decided in agreement with all other authors to publish this paper.

Corresponding author

Correspondence to Katherine A Siminovitch.

Ethics declarations

Competing interests

G.M.H. reports receiving lecture and consultancy fees from Axcan Pharma and A.L.M. received grant support from Novartis and Schering-Plough. J.H. reports receiving lecture fees and grant support from Axcan Pharma.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1 and 2, Supplementary Tables 1–6 and Supplementary Methods (PDF 1209 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hirschfield, G., Liu, X., Han, Y. et al. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet 42, 655–657 (2010). https://doi.org/10.1038/ng.631

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.631

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing